CoreTissue BioEngineering
Tsurumi
About CoreTissue BioEngineering
CoreTissue BioEngineering is a manufacturer of medical equipment that specializes in the development of a tissue-engineered ligament intended for anterior cruciate ligament reconstruction in Japan. The medical devices utilize a distinctive decellularization technology to regenerate damaged tissue. The objective of the company is to assist athletes in returning to competition and achieving their optimal performance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2025)
- Website: coretissue.com
- Phone: +81 036-228-0053
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/coretissue-bioengineering-90354 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.